Clinical effectiveness of Budesonide/Formoterol Fumarate Easyhaler® for patients with poorly controlled obstructive airway disease: a real-world study of patient-reported outcomes

Tamási et al. 2018. Adv Ther

Evaluation of the efficiency of single-inhaler combination therapy with budesonide/formoterol fumarate in patients with bronchial asthma in daily clinical practice

Pirozynski et al. 2017. Adv Ther

Combating climate change with a sustainable inhaler

Wilkinson et al. 2019 BMJ Open

Budesonide/Formoterol Easyhaler: performance under simulated real-life conditions

Haikarainen et al. 2017. Pulm Ther

In vitro flow rate dependency of delivered dose and fine particle dose of Salmeterol/Fluticasone Propionate Easyhaler® and Seretide Diskus® with patient flow rates collected in a randomized controlled trial

Jõgi et al. 2018. JAMP

The Easyhaler® provides accurate and consistent dosing across varying patient inhalation flow rates

Technical review: Easyhaler® provides accurate and consistent dosing across varying patient inhalation flow rates.

Literature review on inhaler selection and device switching — Switching to an Easyhaler device may improve asthma and COPD control without causing additional risks

Lavorini F, et al. 2021 Pulmonary Therapy 

Highlights from Orion’s webinar: Sustainable care of asthma and COPD — partnership between patients and professionals (April 26, 2022)

Enligt forskning är det nyttigt för KOL-patienter att sjunga – 3 positiva sätt att lindra KOL-symtom

Orion Pharma åtar sig att bli koldioxidneutralt senast 2030

Events